ALT5 Sigma adds $TRUMP Coin to its crypto platforms

Published 18/02/2025, 14:38
ALT5 Sigma adds $TRUMP Coin to its crypto platforms

LAS VEGAS - ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech company known for its blockchain solutions with a market capitalization of $97.08 million, has integrated the $TRUMP Coin into its ALT5 Prime trading platform and ALT5 Pay payment system, the company announced today. According to InvestingPro, ALTS has delivered an impressive 576.47% return over the past year. The $TRUMP Coin, which operates on the Solana blockchain, has reached a market capitalization of $17 billion and a daily trading liquidity exceeding $2 billion.

With this addition, ALT5 Pay now enables global merchants to accept $TRUMP Coin as a payment method. Moreover, to address the volatility of cryptocurrency, merchants have the option to automatically convert $TRUMP transactions to USD or a stablecoin, or retain it as cryptocurrency.

Peter Tassiopoulos, CEO of ALT5 Sigma, emphasized the growing utility of cryptocurrency in real-world transactions and the company’s commitment to providing secure and efficient crypto services for various sectors. ALT5 Sigma’s incorporation of $TRUMP Coin is in line with its goal to bridge the traditional financial system with blockchain technology, responding to the increasing global adoption of digital currencies.

ALT5 Sigma, a Nasdaq-listed entity, is also a part of the Russell Microcap Index since June 28, 2024. The company processed over $2 billion in cryptocurrency transactions in 2024 through ALT5 Pay, which allows merchants to accept and process crypto payments seamlessly. With last twelve months revenue of $7.11 million, ALT5 Prime, the company’s over-the-counter trading platform for buying and selling digital assets, continues to gain traction in the digital asset space.

The information provided in this article is based on a press release statement.

In other recent news, ALT5 Sigma Corporation announced two significant developments. The company has partnered with Odoo, a leading provider of integrated business applications, to integrate ALT5 Pay, its cryptocurrency payment gateway, into Odoo’s suite of business applications. This collaboration is set to benefit Odoo’s extensive user base, which spans across 170 countries and includes over 13 million users. ALT5 Sigma has processed over $2 billion in cryptocurrency transactions in 2024 and offers two main platforms: ALT5 Pay and ALT5 Prime.

In another development, ALT5 Sigma expressed its intent to acquire Soin Bioscience LLC’s innovative "clear patch" pain medication technology, facilitated through its subsidiary Alyea Therapeutics Corporation. This move aligns with ALT5’s previously declared intention to separate its biotech operations from its fintech business by the first half of 2025. The completion of the acquisition is contingent upon thorough due diligence, tax structuring, the finalization of definitive agreements, and other standard closing conditions.

These are recent developments that highlight the company’s ongoing efforts to innovate in both the fintech and biotech sectors. While the partnership with Odoo aims to advance blockchain adoption, the proposed acquisition of Soin Bio’s technology could position ALT5 Sigma as a key player in the pharmaceutical industry’s pain management segment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.